AGP Executive Report
Last update: 2 hours agoEbola Vaccine Rollout: DR Congo has received the first batch of Ervebo Ebola vaccine doses—16,250 in Kinshasa late Friday, with a follow-up batch reported at 16,520—part of a 70,000-dose plan from WHO and partners. Clinical Trial Focus: Health authorities say 20,000 doses will go to a Phase 3 trial to test whether Ervebo can protect against the Bundibugyo strain driving this outbreak; the rest (about 50,000) will be used for frontline and health workers. Outbreak Escalation: Confirmed cases have climbed to about 5,290–5,375 with deaths around 2,516–2,557, and UN and Africa CDC officials warn transmission has not peaked and may be far larger than reported. Response Strain: The fight is being hampered by insecurity, attacks on health facilities and workers, difficult transport, and a liquidity problem that delays pay—while WHO keeps the highest emergency alert in place. Kinshasa Risk Checks: With fears the virus could reach the capital, authorities are tightening surveillance and screening along major routes, including river travel into Kinshasa.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
